Gaush Meditech (HKSE:02407) Debt-to-Equity : 0.40 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Debt-to-Equity?

Gaush Meditech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$588.0 Mil. Gaush Meditech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$138.7 Mil. Gaush Meditech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,838.1 Mil. Gaush Meditech's debt to equity for the quarter that ended in Dec. 2023 was 0.40.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Gaush Meditech's Debt-to-Equity or its related term are showing as below:

HKSE:02407' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.46 Med: 0.4 Max: 42.19
Current: 0.4

During the past 5 years, the highest Debt-to-Equity Ratio of Gaush Meditech was 42.19. The lowest was -1.46. And the median was 0.40.

HKSE:02407's Debt-to-Equity is ranked worse than
66.01% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs HKSE:02407: 0.40

Gaush Meditech Debt-to-Equity Historical Data

The historical data trend for Gaush Meditech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech Debt-to-Equity Chart

Gaush Meditech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-0.75

42.19

-1.46

0.51

0.40

Gaush Meditech Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			-1.46	-1.25	0.51	0.47	0.40

Competitive Comparison of Gaush Meditech's Debt-to-Equity

For the Medical Devices subindustry, Gaush Meditech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gaush Meditech's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's Debt-to-Equity falls into.

Gaush Meditech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Gaush Meditech's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(587.999	+	138.662)	/	1838.059
	=	0.40

Gaush Meditech's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(587.999	+	138.662)	/	1838.059
	=	0.40

Gaush Meditech (HKSE:02407) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Gaush Meditech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Gaush Meditech (HKSE:02407) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN

Website

https://www.gaush.com

Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.

Gaush Meditech (HKSE:02407) Headlines

No Headlines